Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

High Starting Infliximab Doses Recommended for Hidradenitis Suppurativa

Key clinical point: For hidradenitis suppurativa, the starting dose of infliximab should be higher than the 5 mg/kg recommended for psoriasis.

Major finding: On a 7.5 mg/kg starting dose of infliximab, average pain scores fell from 5.65 to 1.34 within 4 weeks.

Data Source: A retrospective chart review.

Disclosures: The authors report no potential conflicts of interest.


77th Annual Meeting of the Society for Investigative Dermatology